ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Optimizing Wearable Adherence In A Phase 3 Oncology Trial

  Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.

• AI's Bottleneck In Clinical Trials Moved, And Most People Missed It

  AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.

• How Integrated Technology Solutions Drive Streamline Clinical Trials

  Integrated digital solutions are helping clinical trial managers address significant operational challenges that raise costs and prolong trial durations.

• Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study

  Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO. 

• Why The Everest Group Named Medable A Leader In eCOA

  Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.

• Selecting The Right Site Payments Solution For Today's Clinical Trials: What To Look For

  Are you managing site payments with spreadsheets and manual processes? Discover how automation can reduce administrative burden, improve site relationships, and accelerate clinical trial operations.

• Is The Industry Ready To Trust LLMs With Chart Review?

  See how LLM-powered extraction transforms unstructured medical records into compliant, audit-ready clinical data with machine-scale speed, human oversight, and regulatory-grade accuracy.

• Simply Digital: Trial Technologies Help Reduce Oncology's Burden

  Oncology trials are notorious for presenting participants and sites with many challenges. With the FDA having put its support behind digital tools, learn how they make oncology trials easier for everyone.

• Experts Discuss AI's Future In Pharma

  At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.

• The Case For A Unified eClinical Platform In Clinical Trials

  Coordinating and centralizing eClinical platform functionality is essential to enabling agility and flexibility in the modern clinical trial landscape.